Regenerative medicine deals with processes designed to cure injured or diseased tissue by utilizing specific biological mechanisms as part of therapeutic concepts. Tissue engineering involves constructing tissue structures outside the body or implanting organ substitutes and constructs into the body that are designed to stimulate the formation of tissue structures. These implants are made of biomaterials or cells, or in some cases use biological stimulatory factors. They often comprise a combination of several components.
Our strength in the area of regenerative medicine is based on three factors:
(1) Interdisciplinarity: The NMI brings together different approaches– from engineering and biology to medicine.
(2) Translation: The NMI links partners in a value-added chain – from basic science institutes to industrial companies, to hospitals and clinics.
(3) Expertise: We use a wide range of test methods including cell and tissue culture systems, animal models and molecular analytics based on state-of-the-art equipment. Moreover, we possess comprehensive know-how in the optimization and biomedical evaluation of biomaterials and the use of adult stem cells. Our focused approach helps to significantly accelerate work on new developments.
Current focus is on specific medical indications. These include musculoskeletal diseases, peripheral nerve regenations and blood vessel regeneration and post-operative scarring (adhesion). Multidisciplinary technologies, such as adult stem cell applications ans implant enhancement with therapeutically customized nucleid acids (siRNA), are being actively driven forward.